Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/17/19
End: 12/02/20
Due: 12/02/21
Phase: N/A
Priority: Normal
Start: 07/17/17
End: 06/15/18
Due: 06/15/19
Phase: N/A
Priority: Normal
Start: 01/07/22
End: 09/06/22
Due: 09/06/23
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 07/31/20
Due: 07/31/21
Phase: N/A
Priority: Normal
Start: 08/15/17
End: 04/27/18
Due: 04/27/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Clinical Study Trial of Phenlarmide in China | NCT04164121 | Yiling Pharmaceutical Inc. | user2@example.com | None | 2019-12-17 | 2020-12-02 | 2021-12-02 | - | - | 2025-07-14 |
| A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China | NCT03235778 | Yiling Pharmaceutical Inc. | user2@example.com | None | 2017-07-17 | 2018-06-15 | 2019-06-15 | - | - | 2025-07-14 |
| A Phase I Pharmacokinetics Study for KT07 Capsule | NCT05223660 | Yiling Pharmaceutical Inc. | user2@example.com | None | 2022-01-07 | 2022-09-06 | 2023-09-06 | - | - | 2025-07-14 |
| A Clinical Trial of KT07 Capsule in the U.S.A | NCT02867358 | Yiling Pharmaceutical Inc. | user2@example.com | None | 2016-09-30 | 2020-07-31 | 2021-07-31 | - | - | 2025-07-14 |
| A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China | NCT04162275 | Yiling Pharmaceutical Inc. | user2@example.com | None | 2017-08-15 | 2018-04-27 | 2019-04-27 | - | - | 2025-07-14 |